Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Treatment with dopamine β-hydroxylase (DBH) inhibitors prevents morphine use and relapse-like behavior in rats

View through CrossRef
Abstract Background Opioid use disorders are serious contributors to the harms associated with the drug use. Unfortunately, therapeutic interventions for opioid addicts after detoxification have been limited and not sufficiently effective. Recently, several studies have led to promising results with disulfiram (DSF), a dopamine β-hydroxylase (DBH) inhibitor, showing that it is a potent agent against not only alcohol but also addiction to various drugs. Materials and methods This study was designed to examine whether DSF and nepicastat (NEP; another DBH inhibitor) modify morphine intake and reinstatement of seeking-behavior using the rat model of intravenous morphine self-administration. Additionally, we intended to estimate the effects of both inhibitors on the locomotor activity as well as on extracellular dopamine and its metabolite levels in the nucleus accumbens using microdialysis in naive rats. Results We demonstrated that both DBH inhibitors reduced responding to morphine self-administration. Moreover, DSF and NEP administered acutely before reinstatement test sessions consistently attenuated the reinforcing effects of morphine and a morphine-associated conditioned cue. The observed effects for lower doses (6.25–25 mg/kg; ip) of both DBH inhibitors seem to be independent of locomotor activity reduction and dopamine level in the nucleus accumbens. Neither DSF nor NEP administered daily during morphine abstinence with extinction training sessions had any effect on active lever-responding and changed the reinstatement induced by morphine priming doses. Reinstatement of drug-seeking behavior induced by a conditioned cue previously associated with morphine delivery was attenuated following repeated administration of DSF or NEP during the abstinence period. Conclusion These results seem to point to the significance  of DBH inhibition as a potential pharmacotherapy against morphine use disorders. Graphic abstract
Title: Treatment with dopamine β-hydroxylase (DBH) inhibitors prevents morphine use and relapse-like behavior in rats
Description:
Abstract Background Opioid use disorders are serious contributors to the harms associated with the drug use.
Unfortunately, therapeutic interventions for opioid addicts after detoxification have been limited and not sufficiently effective.
Recently, several studies have led to promising results with disulfiram (DSF), a dopamine β-hydroxylase (DBH) inhibitor, showing that it is a potent agent against not only alcohol but also addiction to various drugs.
Materials and methods This study was designed to examine whether DSF and nepicastat (NEP; another DBH inhibitor) modify morphine intake and reinstatement of seeking-behavior using the rat model of intravenous morphine self-administration.
Additionally, we intended to estimate the effects of both inhibitors on the locomotor activity as well as on extracellular dopamine and its metabolite levels in the nucleus accumbens using microdialysis in naive rats.
Results We demonstrated that both DBH inhibitors reduced responding to morphine self-administration.
Moreover, DSF and NEP administered acutely before reinstatement test sessions consistently attenuated the reinforcing effects of morphine and a morphine-associated conditioned cue.
The observed effects for lower doses (6.
25–25 mg/kg; ip) of both DBH inhibitors seem to be independent of locomotor activity reduction and dopamine level in the nucleus accumbens.
Neither DSF nor NEP administered daily during morphine abstinence with extinction training sessions had any effect on active lever-responding and changed the reinstatement induced by morphine priming doses.
Reinstatement of drug-seeking behavior induced by a conditioned cue previously associated with morphine delivery was attenuated following repeated administration of DSF or NEP during the abstinence period.
Conclusion These results seem to point to the significance  of DBH inhibition as a potential pharmacotherapy against morphine use disorders.
Graphic abstract.

Related Results

Clinical pharmacology of morphine in infants and children
Clinical pharmacology of morphine in infants and children
Morphine is used to treat pain, for treatment of opioid dependence, and neonatal abstinence syndrome. Morphine is modestly absorbed from the gastrointestinal tract whereas after re...
Exploring the in vivo subthreshold membrane activity of phasic firing in midbrain dopamine neurons
Exploring the in vivo subthreshold membrane activity of phasic firing in midbrain dopamine neurons
Dopamine is a key neurotransmitter that serves several essential functions in daily behaviors such as locomotion, motivation, stimulus coding, and learning. Disrupted dopamine circ...
Morphine 6‐glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret
Morphine 6‐glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret
The emetic potencies of morphine and its metabolite morphine 6‐glucuronide have been determined in the ferret by constructing dose‐response curves for mean total retches and vomits...
Association of Dopamine β-Hydroxylase Polymorphism rs1611115 And Serum Levels with Psychiatric Disorders in Pakistani Population
Association of Dopamine β-Hydroxylase Polymorphism rs1611115 And Serum Levels with Psychiatric Disorders in Pakistani Population
Abstract Dopamine β-hydroxylase (DBH) is a copper-containing enzyme that has an important role in maintaining the cellular homeostasis between the two neurotransmitters, do...
Dopamine and cyclic AMP‐regulated phosphoprotein‐32 phosphorylation pattern in cocaine and morphine‐sensitized rats
Dopamine and cyclic AMP‐regulated phosphoprotein‐32 phosphorylation pattern in cocaine and morphine‐sensitized rats
AbstractThis study reports some of the modifications in dopaminergic signalling that accompany cocaine and morphine behavioural sensitization. Cocaine‐sensitized rats showed increa...
Abstract 1856: Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
Abstract 1856: Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
Abstract ONC201 (originally discovered as TRAIL-Inducing Compound #10 or TIC10) and analogue ONC206 have been found to induce an integrated stress response with sugg...

Back to Top